Fundraising FoxTullis Health Investors — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Board seatCurt LaBelle· per SEC Form D · $28M raise · filed Jul 2024
Co-investorsAvestria VenturesForeground CapitalLaerdal Million Lives FundGlobal Health Investment Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.